Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction

2 years ago

Results Demonstrate the Active Pharmaceutical Ingredient in Cardiol's Novel CRD-38 Formulation Attenuates Harmful Fat Distribution and Key Markers of Cardiac…

Defence Announces Peer-reviewed Publication of Its Preclinical Data on Accum(R) as an Anti-Cancer Molecule in the Journal of Cancer Science

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - October 10, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"…

Berlin Cures takes next step in battle against Long COVID

2 years ago

Collaboration with Uniklinikum Erlangen as 5th German research centerBERLIN, GERMANY / ACCESSWIRE / October 10, 2023 / Berlin Cures, a…

Relief Therapeutics Announces that more than 400,000 of its ADRs are Currently Outstanding and that, as a Result, the Company has Achieved an Important NASDAQ Initial Listing Milestone

2 years ago

GENEVA, SWITZERLAND / ACCESSWIRE / October 10, 2023 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical…

IRLAB Signs Phase III Regulatory US Consultants to Support Preparation for Mesdopetam’s end-of-Phase 2 Meeting with the US FDA

2 years ago

GOTHENBURG, SWEDEN / ACCESSWIRE / October 10, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company…

iHealth to Offer Savings Up to 63% on Best Sellers During Amazon October Prime Big Deal Days

2 years ago

Featured Essential Healthcare Products Include Country's Preferred At-Home Covid TestSUNNYVALE, CA / ACCESSWIRE / October 10, 2023 / iHealth Labs,…

ProAssurance Announces Dates for Release of Third Quarter 2023 Results Release and Investor Teleconference

2 years ago

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended September 30, 2023 after the close of normal…

Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023

2 years ago

ENGLEWOOD, CO / ACCESSWIRE / October 9, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a pharmaceutical company…

Is Nutrition the Answer to Long-COVID? A Clinical Trial Will Explore the Impacts of the Medical Food KetoCitra Together With a Low-Carbohydrate Diet

2 years ago

SANTA BARBARA, CA / ACCESSWIRE / October 9, 2023 / Santa Barbara Nutrients, Inc. is pleased to announce that our…

Healee Announces New CEO with Extensive Expertise in Healthcare Technology Leadership, AI and Data Science Research

2 years ago

Plamen Petrov, Ph.D. to debut at HLTH 2023 with Healee’s innovative patient access solutionGREAT NECK, N.Y.--(BUSINESS WIRE)--Healee has announced the…